The effects of testosterone supplementation on cognitive functioning in older men

CNS and Neurological Disorders - Drug Targets

Volumn 15, Issue 3, 2016, Pages 337-343

  Wahjoepramono, Eka J ^a,b   Asih, Prita R ^a,b,c   Aniwiyanti, Vilia ^b   Taddei, Kevin ^a,c   Dhaliwal, Satvinder S ^d   Fuller, Stephanie J ^c   Foster, Jonathan ^d   Carruthers, Malcolm ^a,e   Verdile, Giuseppe ^a,c,d   Sohrabi, Hamid R ^a,c   Martins, Ralph N ^a,c  

^a EDITH COWAN UNIVERSITY   (Australia)

^b PELITA HARAPAN UNIVERSITY   (Indonesia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d CURTIN UNIVERSITY   (Australia)

^e Centre for Mens Health   (United Kingdom)

Author keywords

Ageing; Alzheimer s disease; Androgen; Apolipoprotein E; Cognition; Dementia; Depression; Memory; Testosterone

Indexed keywords

ANDROSTANOLONE; APOLIPOPROTEIN E; ESTRADIOL; LUTEINIZING HORMONE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; APOLIPOPROTEIN E4;

ADULT; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; GERIATRIC DEPRESSION SCALE; HUMAN; MALE; MEDICAL PROCEDURES; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; RANDOMIZED CONTROLLED TRIAL; RECALL; REY AUDITORY VERBAL LEARNING TEST; TESTOSTERONE SUPPLEMENTATION; VERBAL MEMORY; AGED; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; COGNITIVE DEFECT; COMPLICATION; DIET THERAPY; DIETARY SUPPLEMENT; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FOLLOW UP; GENETICS; MENTAL HEALTH; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; APOLIPOPROTEIN E4; COGNITION DISORDERS; DEPRESSION; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESTRADIOL; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84961589473     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527315666151110125704     Document Type: Article

References (34)

1. Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Harman SM, Resnick SM. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 2002; 87(11): 5001-7.
2. Verdile G, Laws SM, Henley D, et al. Associations between gonadotropins, testosterone and beta amyloid in men at risk of Alzheimer's disease. Mol Psychiatry 2014; 19(1): 69-75.
3. Asih PR, Wahjoepramono EJ, Aniwiyanti V, et al. Testosterone replacement therapy in older male subjective memory complainers: double-blind randomized crossover placebo-controlled clinical trial of physiological assessment and safety. CNS Neurol Disord Drug Targets 2015; 14(5): 576-86.
4. Saad F, Yassin A, Haider A, Doros G, Gooren L. Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men. Korean J Urol 2015; 56(4): 310-7.
5. Verdile G, Asih PR, Barron AM, Wahjoepramono EJ, Ittner LM, Martins RN. The impact of luteinizing hormone and testosterone on beta amyloid (Abeta) accumulation: Animal and human clinical studies. Horm Behav 2015; 76: 81-90.
6. Bassil N, Alkaade S, Morley JE. The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag 2009; 5(3): 427-48.
7. Tan RS, Pu SJ. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Aging Male 2003; 6(1): 13-7.
8. Seidl JNT, Massman PJ. Relationships Between Testosterone Levels and Cognition in Patients With Alzheimer Disease and Nondemented Elderly Men. J Geriatr Psychiatry Neurol 2014; 28(1): 27-39.
9. Burkhardt MS, Foster JK, Clarnette RM, et al. Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men. J Clin Endocrinol Metab 2006; 91(3): 1168-72.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189-98.
11. Lezak MD. Neuropsychological assessment. 2 ed. New York: Oxford University Press; 1983.
12. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982; 17(1): 37-49.
13. Slabbekoorn D, van Goozen SH, Megens J, Gooren LJ, Cohen- Kettenis PT. Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals. Psychoneuroendocrinology 1999; 24(4): 423-47.
14. Wallen K, Rupp HA. Women's interest in visual sexual stimuli varies with menstrual cycle phase at first exposure and predicts later interest. Horm Behav 2010; 57(2): 263-8.
15. Dysken MW, Sano M, Asthana S, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAMAD VA cooperative randomized trial. JAMA 2014; 311(1): 33-44.
16. La Fata G, Weber P, Mohajeri MH. Effects of vitamin E on cognitive performance during ageing and in Alzheimer's disease. Nutrients 2014; 6(12): 5453-72.
17. Haren MT, Wittert GA, Chapman IM, Coates P, Morley JE. Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status. Maturitas 2005; 50(2): 124-33.
18. Kenny AM, Fabregas G, Song C, Biskup B, Bellantonio S. Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci 2004; 59(1): 75-8.
19. Hogervorst E, De Jager C, Budge M, Smith AD. Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology 2004; 29(3): 405-21.
20. Cherrier MM, Anderson K, Shofer J, Millard S, Matsumoto AM. Testosterone treatment of men with mild cognitive impairment and low testosterone levels. Am J Alzheimers Dis Other Dement 2015; 30(4): 421-30.
21. Cherrier MM, Matsumoto AM, Amory JK, et al. Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men. Psychoneuroendocrinology 2007; 32(1): 72-9.
22. Aleman A, de Vries WR, Koppeschaar HP, et al. Relationship between circulating levels of sex hormones and insulin-like growth factor-1 and fluid intelligence in older men. Exp Aging Res 2001; 27(3): 283-91.
23. Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA 2008; 299(1): 39-52.
24. Lakshman KM, Kaplan B, Travison TG, et al. The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab 2010; 95(8): 3955-64.
25. Hogervorst E, Matthews FE, Brayne C. Are optimal levels of testosterone associated with better cognitive function in healthy older women and men? Biochim Biophys Acta 2010; 1800(10): 1145-52.
26. Chodosh J, Kado DM, Seeman TE, Karlamangla AS. Depressive symptoms as a predictor of cognitive decline: MacArthur Studies of Successful Aging. Am J Geriatr Psychiatry 2007; 15(5): 406-15.
27. Richard E, Schmand B, Eikelenboom P, et al. Symptoms of apathy are associated with progression from mild cognitive impairment to Alzheimer's disease in non-depressed subjects. Dement Geriatr Cogn Disord 2012; 33(23): 204-9.
28. Wong SY, Leung JC, Kwok T, et al. Low DHEAS levels are associated with depressive symptoms in elderly Chinese men: results from a large study. Asian J Androl 2011; 13(6): 898-902.
29. Seidman SN, Weiser M. Testosterone and mood in aging men. Psychiatr Clin N Am 2013; 36(1): 177-82.
30. Giltay EJ, Tishova YA, Mskhalaya GJ, Gooren LJ, Saad F, Kalinchenko SY. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. J Sex Med 2010; 7(7): 2572-82.
31. Shores MM, Kivlahan DR, Sadak TI, Li EJ, Matsumoto AM. A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression). J Clin Psychiatry 2009; 70(7): 1009-16.
32. Wampold BE, Minami T, Tierney SC, Baskin TW, Bhati KS. The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials. J Clin Psychol 2005; 61(7): 835-54.
33. Geers AL, Weiland PE, Kosbab K, Landry SJ, Helfer SG. Goal activation, expectations, and the placebo effect. J Pers Soc Psychol 2005; 89(2): 143-59.
34. Ernst E. Placebo: new insights into an old enigma. Drug Discov Today 2007; 12(910): 413-8.